Atrium Therapeutics Inc RNA Q1 2026 Earnings Narrower Loss Drives EPS Beat but Stock Slips ALLO Q1 2026 Earnings Narrower Loss Than Expected but Stock Declines DOUG Q4 2025 Earnings Significant EPS Miss Amid Challenging Real Estate Market PEPG Q1 2026 Earnings NarrowerthanExpected Loss Reflects Cost Discipline Amid Clinical Progress CMPS Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Psychedelic Therapy Development TSLX Q1 2026 Earnings Misses EPS Estimates as Net Investment Income Dips Shares Edge Higher SE Q1 2026 Earnings EPS Misses Estimates Stock Dips Slightly PZZA Q1 2026 Earnings EPS Misses Estimates by 1155 Amid Cost Pressures SD Q1 2026 Earnings EPS Surges Past Estimates by 3734 Revenue Data Unavailable StepStone Group STEP Q1 2026 Earnings EPS Surges Past Estimates Yet Shares Pull Back